Scott V. Dindot

Scott V. Dindot is an Associate Professor in the Department of Veterinary Pathobiology at Texas A&M University, affiliated with the School of Medicine. His research focuses on epigenetic and genetic mechanisms underlying phenotypic variation and disease, particularly genomic imprinting and structural variants in conditions like Angelman syndrome. He holds a PhD from Texas A&M University (2003) and completed postdoctoral training at Baylor College of Medicine (2002–2008).

His research interests include understanding the interplay of genetics, epigenetics, and gene regulation in disease contexts. His work utilizes genetically engineered models, domestic animals, and molecular tools to study imprinting disorders and structural variants. Key areas include Angelman syndrome pathogenesis, therapeutic antisense oligonucleotide development, and microbiome interactions in disease models.

Recent publications highlight preclinical models of Angelman syndrome, antisense therapies, and gut microbiome analyses in disease. His lab has developed rat and pig models to study disease mechanisms and therapeutic efficacy, with a focus on translational applications.

Dr. Dindot’s work bridges basic science and clinical translation, addressing neurological disorders through innovative genetic and epigenetic approaches. He is based at the VMR Building in College Station, Texas.